Cervélo TestTeam’s Xavier Florencio has been suspended by his team on the eve of the Tour de France after he was found to have violated the squad’s anti-doping policies by using medication without notifying medical staff.
In a statement issued Friday night, the team announced a decision to withdraw his entry in the Tour “due to a violation of internal policies.”
“Consistent with the team’s internal values, TestTeam riders are required to obtain permission from the team’s medical staff before they can use any supplements or medication,” the team reported. “This evening, the team learned that Xavier Florencio has been using a substance containing ephedrine to treat a saddle discomfort. This substance was not cleared in advance with the medical staff. This usage without clearance violates the internal policy.”
The team noted that its management was trying to determine whether Florencio can or will be replaced in advance of Saturday’s prologue.